Cargando…

Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death worldwide. HCC progression and metastasis are closely related to altered mitochondrial metabolism, including mitochondrial stress responses, metabolic reprogramming, and mitoribosomal defects. Mitochondrial oxidative phospho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ho-Yeop, Nga, Ha Thi, Tian, Jingwen, Yi, Hyon-Seung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391498/ https://www.ncbi.nlm.nih.gov/pubmed/34440674 http://dx.doi.org/10.3390/cells10081901

Ejemplares similares

Interleukin-10 Attenuates Liver Fibrosis Exacerbated by Thermoneutrality
por: Nga, Ha Thi, et al.
Publicado: (2021)

Metabolite Changes during the Transition from Hyperthyroidism to Euthyroidism in Patients with Graves’ Disease
por: Lee, Ho Yeop, et al.
Publicado: (2022)

Immunometabolic signatures predict recovery from thyrotoxic myopathy in patients with Graves' disease
por: Setoyama, Daiki, et al.
Publicado: (2021)

Leucine-enriched amino acid supplementation and exercise to prevent sarcopenia in patients on hemodialysis: a single-arm pilot study
por: Ju, Sang-Hyeon, et al.
Publicado: (2023)

Hepatic T-cell senescence and exhaustion are implicated in the progression of fatty liver disease in patients with type 2 diabetes and mouse model with nonalcoholic steatohepatitis
por: Sim, Byeong Chang, et al.
Publicado: (2023)

The mitochondrial unfolded protein response and mitohormesis: a perspective on metabolic diseases
por: Yi, Hyon-Seung, et al.
Publicado: (2018)

TCA Cycle Rewiring as Emerging Metabolic Signature of Hepatocellular Carcinoma
por: Todisco, Simona, et al.
Publicado: (2019)

Oncogenes, mitochondrial metabolism, and quality control in differentiated thyroid cancer
por: Yi, Hyon-Seung, et al.
Publicado: (2017)

A metabolism-associated gene signature for prognosis prediction of hepatocellular carcinoma
por: Tian, Yilin, et al.
Publicado: (2022)

Skeletal muscle mitoribosomal defects are linked to low bone mass caused by bone marrow inflammation in male mice
por: Tian, Jingwen, et al.
Publicado: (2022)

Effect of Salivary Exosomal miR-25-3p on Periodontitis With Insulin Resistance
por: Byun, Jin-Seok, et al.
Publicado: (2022)

Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases
por: Yi, Hyon-Seung
Publicado: (2019)

Metabolism-Associated Gene Signatures for FDG Avidity on PET/CT and Prognostic Validation in Hepatocellular Carcinoma
por: Lee, Hyunjong, et al.
Publicado: (2022)

HVPG signature: A prognostic and predictive tool in hepatocellular carcinoma
por: Qi, Xiaolong, et al.
Publicado: (2016)

Mitochondrial uncoupling and the disruption of the metabolic network in hepatocellular carcinoma
por: Turcios, Lilia, et al.
Publicado: (2020)

Development and Verification of a Combined Immune- and Metabolism-Related Prognostic Signature for Hepatocellular Carcinoma
por: Guo, Yuanyuan, et al.
Publicado: (2022)

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
por: Weng, Jialei, et al.
Publicado: (2021)

Mitoribosomal defects aggravate liver cancer via aberrant glycolytic flux and T cell exhaustion
por: Song, Byong-Sop, et al.
Publicado: (2022)

Novel Prognostic Signatures of Hepatocellular Carcinoma Based on Metabolic Pathway Phenotypes
por: Ye, Tingbo, et al.
Publicado: (2022)

A novel metabolism-related gene signature in patients with hepatocellular carcinoma
por: Ru, Bin, et al.
Publicado: (2023)

Unraveling the Janus-Faced Role of Autophagy in Hepatocellular Carcinoma: Implications for Therapeutic Interventions
por: Nguyen, Thi Ha, et al.
Publicado: (2023)

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
por: Nakagawa, Hayato, et al.
Publicado: (2018)

Metabolic alterations and vulnerabilities in hepatocellular carcinoma
por: Tenen, Daniel G, et al.
Publicado: (2020)

Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular Carcinoma
por: Yuan, Chaoyan, et al.
Publicado: (2021)

Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma
por: Tang, Chaozhi, et al.
Publicado: (2020)

Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma
por: Zhu, Zhipeng, et al.
Publicado: (2020)

Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
por: Tang, Linsong, et al.
Publicado: (2022)

Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma
por: Guan, Qiutong, et al.
Publicado: (2022)

A Novel Purine and Uric Metabolism Signature Predicting the Prognosis of Hepatocellular Carcinoma
por: Yang, Shengjie, et al.
Publicado: (2022)

Erratum: A metabolism- associated gene signature for prognosis prediction of hepatocellular carcinoma
por: Frontiers Production Office,
Publicado: (2023)

Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma
por: Tang, Xiaolong, et al.
Publicado: (2023)

Inhibition of Kynurenine Metabolism and Its Effect in Mitochondrial Function in Hepatocellular Carcinoma
por: Castro-Portuguez, Raul, et al.
Publicado: (2020)

Circular RNA Signature in Hepatocellular Carcinoma
por: Qiu, Lipeng, et al.
Publicado: (2019)

Novel miRNA signature for predicting the stage of hepatocellular carcinoma
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2020)

Alternative Splicing in Hepatocellular Carcinoma
por: Lee, Seung Eun, et al.
Publicado: (2020)

A Five-Gene-Based Prognostic Signature for Hepatocellular Carcinoma
por: Tian, Dazhi, et al.
Publicado: (2021)

Autophagy-Related Signatures as Prognostic Indicators for Hepatocellular Carcinoma
por: Ye, Wen, et al.
Publicado: (2022)

microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma
por: Burchard, Julja, et al.
Publicado: (2010)

Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma
por: Sangineto, Moris, et al.
Publicado: (2020)

A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma
por: Wang, Zhihao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p3t8dhb4amd5ij2no9qfb8us7l